Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses

Current treatment options for influenza virus infections in humans are limited and therefore the development of novel antivirals is of high priority. Inhibiting influenza virus attachment to host cells would provide an early and efficient block of the infection and thus, receptor analogs have been c...

Descripción completa

Detalles Bibliográficos
Autores principales: Günther, Sira Carolin, Maier, Julian David, Vetter, Janine, Podvalnyy, Nikita, Khanzhin, Nikolay, Hennet, Thierry, Stertz, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972948/
https://www.ncbi.nlm.nih.gov/pubmed/31964943
http://dx.doi.org/10.1038/s41598-020-57608-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972948/
https://www.ncbi.nlm.nih.gov/pubmed/31964943
http://dx.doi.org/10.1038/s41598-020-57608-4

Ejemplares similares